Novel tool confers targeted, stable editing of epigenome in human stem cells

May 4, 2017
Neurons from Angelman syndrome (AS) patients lack expression of the UBE3A protein due to an epigenetic defect. The new Salk technology restores normal expression of the UBE3A protein in neurons derived from the cells of an AS patient (pictured) by correcting the aberrant methylation pattern. Credit: Salk Institute/Waitt Center

Salk Institute scientists have developed a novel technology to correct disease-causing aberrations in the chemical tags on DNA that affect how genes are expressed. These types of chemical modifications, collectively referred to as epigenetics or the epigenome, are increasingly being considered as important as the genomic sequence itself in development and disease.

The new Salk technology, which is described in the journal Science on May 4, 2017, was used to model mutations in the epigenome associated with and to restore proper methylation patterns in stem cells derived from patients suffering from Angelman syndrome (AS), a rare neurodegenerative disorder often misdiagnosed as autism. In addition to modeling and treating epigenetic disorders, the technology also holds promise for studying human development and biology in general.

"We are excited at how many new avenues this work opens up for understanding disease processes and developing effective new therapies," says Salk Professor Juan Carlos Izpisua Belmonte, senior author of the paper and holder of Salk's Roger Guillemin Chair. "It was a giant step to discover how to edit the genome—this technology to edit the epigenome is another leap forward."

Izpisua Belmonte's lab recently pioneered a method to modify in nondividing cells, which make up the majority of adult tissues. The new technique goes beyond genes to target the most common type of epigenetic change, called DNA methylation, in which chemical tags called groups attach to DNA. Typically these tags mark the gene as ready to be turned on or off. More and more, scientists are learning that DNA methylation is involved in a range of physiological and pathological processes from embryonic development to the onset of certain diseases later in life, including cancer. Researchers have discovered ways of altering on short DNA sequences, but no one has been able to make the changes stick over a broad range (a prerequisite for proper gene activation or inactivation) until now.

The video will load shortly.
New Salk technology adds methyl groups at specific positions on DNA, allowing targeted gene correction of aberrant epigenetic disorders Credit: Salk Institute

Because 80 percent of mammalian DNA is methylated, the Izpisua Belmonte lab was curious about regions that are unmethylated. Paradoxically, these regions are often rich in potential methylation sites and tend to be close to regions of genes where transcription of genetic information begins. Yet somehow these regions, which are called CpG islands, normally remain unmethylated.

The researchers hypothesized that interfering with CpG islands might trigger new methylation. To test this hypothesis, the team first used molecular tools to insert DNA without CpGs into the island close to the MLH1 gene. MLH1 is normally unmethylated but leads to an increased risk of colon cancer if it becomes methylated. The team was able to mimic the aberrant methylation in the colon cancer gene as a proof of principle to begin to understand how abnormal methylation is associated with cancers.

"What is interesting about CpG islands is that they resist methylation," says Yuta Takahashi, a Salk research associate and first author of the paper. "But by introducing CpG-free DNA, we can override the machinery that blocks it and then induce DNA methylation of the entire island."

This illustration represents editing of the epigenome by the new Salk technology. Top: open circles indicate aberrant methylation of the disease state. Bottom: Black circles indicate proper methylation induced by precise insertion of CpG-free DNA into a CpG island. The Salk team tested the technology in modeling colon cancer epimutations in human pluripotent cells, and to correct epigenetic defects in cells from a patient with Angelman syndrome (AS). Credit: Salk Institute

Knowing they could induce methylation where it doesn't belong, the team next tried to attach methyl tags where they do belong on a genome but are missing, such as in some diseases. Angelman syndrome (AS) results from aberrant DNA methylation, which causes a loss of the UBE3A protein in neurons. This leads to cognitive deficits in patients. By using their technology, the team corrected the abnormal DNA methylation and restored UBE3A protein levels in AS neuronal cells in a dish.

Most exciting, according to the researchers, was the fact that all the methylation patterns they introduced were stable over time, which has not been true of other epigenetic technologies. Even removing the CpG-free DNA did not affect the new methylation. The finding offers a way to rewrite epigenetic marks on CpG islands, as well as providing insight into the mechanism by which CpG islands are protected from DNA methylation.

"It's wonderful that we have developed a new technology that allows for robust editing of the DNA methylome at CpG islands in pluripotent stem cells, which will help develop cell-replacement therapeutics for epigenetic disorders," says Jun Wu, a Salk staff scientist and one of the paper's coauthors. "But by discovering the underlying mechanisms of DNA methylation, we hope to do even more with this ."

Explore further: DNA labels predict mortality

More information: "Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells" Science (2017). science.sciencemag.org/cgi/doi … 1126/science.aag3260

Related Stories

DNA labels predict mortality

March 20, 2017
Various chemical modifications in the genome determine whether genes are read or deactivated. Methyl labels in the DNA play a key role in this "epigenetic" regulation of gene activity. Life style and environmental factors ...

New methodology tracks changes in DNA methylation in real time at single-cell resolution

September 24, 2015
Whitehead Institute researchers have developed a methodology to monitor changes in DNA methylation over time in individual cells.

Inherited parental methylation shifts over time, may have functional effects in the brain and other tissues

September 20, 2016
Parental imprinting—a form of gene control passed down from parents to offspring—is far more dynamic than previously thought and may contribute to changes in the brain and other tissues over time. This finding by Whitehead ...

Obesity reprogrammes muscle stem cells

February 22, 2017
Obesity is associated with reduced muscle mass and impaired metabolism. Epigenetic changes that affect the formation of new muscle cells may be a contributing factor, according to new research from Lund University, Sweden.

Scientists reveal epigenome maps of the human body's major organs

June 1, 2015
For more than a decade, scientists have had a working map of the human genome, a complete picture of the DNA sequence that encodes human life. But new pages are still being added to that atlas: maps of chemical markers called ...

Recommended for you

Study reveals an ancient Achilles heel in the human genome

September 21, 2017
In a major study published today, researchers at deCODE genetics use whole-genome data from 14,000 people from across the population of Iceland, including 1500 sets of parents and children, to provide the most detailed portrait ...

Forgotten strands of DNA initiate the development of immune cells

September 21, 2017
Intricate human physiological features such as the immune system require exquisite formation and timing to develop properly. Genetic elements must be activated at just the right moment, across vast distances of genomic space.

Genome editing reveals role of gene important for human embryo development

September 20, 2017
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development. This is the first time that genome editing has been used to study gene function in human ...

A piece of the puzzle: Eight autism-related mutations in one gene

September 19, 2017
Scientists have identified a hotspot for autism-related mutations in a single gene.

Scientists identify key regulator of male fertility

September 19, 2017
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.

New assay leads to step toward gene therapy for deaf patients

September 18, 2017
Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.